Creams play an important role in the treatment of plaque psoriasis to help improve the appearance of the skin and reduce itching. New medicines that target the underlying inflammation caused by plaque ...
Although some people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...
Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...
ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% of ...
Findings showed 64.7% of icotrokinra-treated patients achieved IGA scores 0/1 and 49.6% achieved PASI 90 compared with 8.3% and 4.4% of those on placebo, respectively. Topline results were announced ...
Catching psoriasis early is vital for managing the disease effectively and minimizing its impact on your quality of life. Timely intervention can help slow disease progression, alleviate symptoms, and ...
My skin journey started six years ago when I noticed three reddish dots on my calves. At the time, I thought it was nothing—I was used to having sensitive skin and allergic reactions growing up. Then, ...
84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ICONIC-LEAD is the first ever Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback